A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome
Public ClinicalTrials.gov record NCT02915159. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Primary Sjögrens Syndrome
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy of abatacept compared to placebo in patients with Sjögren's Syndrome.
Study identification
- NCT ID
- NCT02915159
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 250 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 6, 2016 (Actual)
- Primary completion
- Aug 7, 2018 (Actual)
- Completion
- Jul 23, 2019 (Actual)
- Last update posted
- Aug 10, 2020
2016 – 2019
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Jude Hospital Yorba Linda | Fullerton | California | 92835 | — |
| Riverside Medical Clinic | Riverside | California | 92506 | — |
| Colorado Arthritis Associates | Lakewood | Colorado | 80228 | — |
| North Georgia Rheumatology Group | Lawrenceville | Georgia | 30046 | — |
| Intermountain Research Center Inc. | Boise | Idaho | 83702 | — |
| Johns Hopkins University | Baltimore | Maryland | 21224 | — |
| Clinical Pharmacology Study Group | Worcester | Massachusetts | 01605 | — |
| St. Paul Rheumatology, P.A. | Eagan | Minnesota | 55121 | — |
| Northwell Health | Great Neck | New York | 11021 | — |
| Local Institution | Charlotte | North Carolina | 28203 | — |
| Joint and Muscle Medical Care and Research Institute (JMMCRI) | Charlotte | North Carolina | 28204 | — |
| Duke Clinical Research Unit, Duke Univ Med Ctr, Duke South | Durham | North Carolina | 27710 | — |
| Health Research Of Oklahoma | Oklahoma City | Oklahoma | 73103 | — |
| East Penn Rheumatology | Bethlehem | Pennsylvania | 18015 | — |
| Altoona Center For Clinical Research | Duncansville | Pennsylvania | 16635-8406 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| West Tennessee Research Institute | Jackson | Tennessee | 38305 | — |
| Metroplex Clinical Research Center | Dallas | Texas | 75231 | — |
| Scott Zashin Inc. | Dallas | Texas | 75231 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02915159, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 10, 2020 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02915159 live on ClinicalTrials.gov.